.

L86 - FARIDKOT CC4

SUKHRAJ KAUR SHOP NO 4 GGS MEDICAL
HOSPITAL SADIQ ROAD
FARIDKOT

Name : Mrs. OKENDRO Collected : 27/12/2019 2:11:00PM

Received : 28/12/2019 12:28:59PM
Lab No. : 275175927 Age: 30 Years Gender: Female Reported : 30/12/2019 4:37:36PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

MATERNAL SERUM SCREEN 4; QUADRUPLE TEST @

(CLIA)
AFP 33.6 ng/mL

HCG 9187.00 mIU/mL

ESTRIOL, FREE 0.97 ng/mL

INHIBIN A 276.20 pg/mL

Interpretation
----------------------------------------------------------------
| WEEKS OF | AFP | HCG | ESTRIOL,FREE | INHIBIN A|
| GESTATION| MEDIANS | MEDIANS | MEDIANS | MEDIANS |
| | (ng/ml) | (mIU/ml) | (ng/ml) | (pg/ml) |
|----------|-------------|-------------|--------------|----------|
| 14 | 27.20 | 40370 | 0.37 | 208.75 |
|----------|-------------|-------------|--------------|----------|
| 15 | 32.01 | 32200 | 0.55 | 222.90 |
|----------|-------------|-------------|--------------|----------|
| 16 | 37.67 | 25690 | 0.76 | 194.20 |
|----------|-------------|-------------|--------------|----------|
| 17 | 44.33 | 20490 | 1.00 | 201.30 |
|----------|-------------|-------------|--------------|----------|
| 18 | 52.16 | 16340 | 1.25 | 196.20 |
|----------|-------------|-------------|--------------|----------|
| 19 | 61.38 | 13040 | 1.50 | 226.90 |
|----------|-------------|-------------|--------------|----------|
| 20 | 72.33 | 10400 | 1.76 | 253.70 |
|----------|-------------|-------------|--------------|----------|
| 21 | 85.00 | 8295 | 1.99 | 282.10 |
|----------|-------------|-------------|--------------|----------|
| 22 | 100.02 | 6620 | 2.30 | 292.30 |
----------------------------------------------------------------

------------------------------------------------------------
| Abnormality | Cut off | Detection Rate | False Positve |
|-------------|-------------|----------------|---------------|
| Neural tube | >=2.5 MoM | 70-75% | 2-4% |
| defects | | | |
|-------------|-------------|----------------|---------------|
| Trisomy 21 | 1:250 | 75-80% | 5% |
| (Down) | | | |
|-------------|-------------|----------------|---------------|
| Trisomy 18 | 1:100 | 60% | 0.3% |
------------------------------------------------------------

Note
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*275175927*
Page 1 of 4
.

L86 - FARIDKOT CC4

SUKHRAJ KAUR SHOP NO 4 GGS MEDICAL
HOSPITAL SADIQ ROAD
FARIDKOT

Name : Mrs. OKENDRO Collected : 27/12/2019 2:11:00PM

Received : 28/12/2019 12:28:59PM
Lab No. : 275175927 Age: 30 Years Gender: Female Reported : 30/12/2019 4:37:36PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

· Statistical evaluation has been done using CE marked PRISCA 5 software.
· Screening tests are based on statistical analysis of patient demographic and biochemical data. They
simply indicate a high or low risk category. Confirmation of screen positives is recommended in the
amniotic fluid.
· The interpretive unit is MoM (Multiples of Median) which takes into account variables such as
gestational age (ultrasound), maternal weight, race, insulin dependent Diabetes, multiple gestation, IVF
(Date of Birth of Donor, if applicable), smoking & previous history of Down syndrome. Accurate
availability of this data for Risk Calculation is critical.
· Ideally all pregnant women should be screened for Prenatal disorders irrespective of maternal age. The
test is valid between 14-22 weeks of gestation, but ideal sampling time is between 15-20 weeks
gestation.

Comments
Second trimester screening for Prenatal disorders (Trisomy 21 & 18 and Open Neural Tube defects) is
essential to identify those women at sufficient risk for a congenital anomaly in the fetus to warrant further
evaluation and followup. These are screening procedures which cannot discriminate all affected pregnancies
from all unaffected pregnancies. Screening cutoffs are established by using MoM values that maximize the
detection rate and minimize false positives. Addition of Inhibin A analysis to the Triple test protocol increases
the detection rate of Down syndrome from 65% to 75%.

Dr Himangshu Mazumdar Dr Nimmi Kansal

MD, Biochemistry MD, Biochemistry
Senior Consultant - Clinical Chemistry National Head - Clinical Chemistry &
& Biochemical Genetics Biochemical Genetics
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*275175927*
Page 2 of 4
.

L86 - FARIDKOT CC4

SUKHRAJ KAUR SHOP NO 4 GGS MEDICAL
HOSPITAL SADIQ ROAD
FARIDKOT

Name : Mrs. OKENDRO Collected : 27/12/2019 2:11:00PM

Received : 28/12/2019 12:28:59PM
Lab No. : 275175927 Age: 30 Years Gender: Female Reported : 30/12/2019 4:37:36PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

IMPORTANT INSTRUCTIONS

*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*275175927*
Page 3 of 4
.

MATERNAL SERUM SCREEN 4 RESULTS

Name OKENDRO Race Asian
Ref. By IVF no
Lab. No. 275175927 Diabetes no Smoking no
Date of Birth 01/04/89 Weight 78 kg Previous Trisomy
unknown
Age at 21 pregancies
Delivery 31.2 Years Twins No Sampling Date 27/12/19
Measured Serum Values, Corrected MOM's and Risk Evaluation
Analyte Value Units Corr. MOM's LMP Date :
AFP 33.6 ng/ml 0.86
Ultrasound Date : 23/12/19
fE3 1.0 ng/ml 0.90
Gestational Age by USG : 17 + 3
HCG 9187.0 mIU/ml 0.63
Inhibin-A 276.2 pg/ml 1.55 Gestational Age at sampling date : 18 + 0
Risk
Trisomy 21 Risk
1:10 at term
1:2394

Trisomy 18 Risk
1:100 <1:10000
1:250 Cut off
Neural Tube
Defects Risk
1:1000 <1:10000

1:10000 Age Risk

1:835
13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 Age

NEURAL TUBE DEFECTS SCREENING TRISOMY 21 SCREENING

SCREEN NEGATIVE
The calculated risk for spina bifida is <1:10000.
There is no statistical indication for spina bifida.
Anencephaly has been excluded by ultrasound.
TRISOMY 18 SCREENING
SCREEN NEGATIVE
The calculated risk for trisomy 18 is <1:10000.
There is no statistical indication for trisomy 18
risk
SCREEN NEGATIVE
The calculated risk for Trisomy 21 is below the cut
off which represents a low risk.
It is expected that among 2394 women with the same
data, there is one woman with a trisomy 21 pregnancy
and 2393 women with normal pregnancies.
The calculated risk by PRISCA depends on the
accuracy of the information provided by the referring
physician.
Please note that Risk calculations are statistical
approaches and have limited diagnostics value.

COMMENTS
DR. NIMMI KANSAL
AUTHORIZED BY
Report Printing Date: 30. Dec 2019 PRISCA 5.2.0.13 Dr. Lal Pathlabs Pvt. Ltd.
below cut off Below Cut Off, but above Age Risk above cut off
Page 4 of 4